H1 Antihistamines | List of Frontiers open access articles

Brief Research Report

Published on 21 May 2020

Primary Non-Adherence to Antihistamines—Conclusions From E-Prescription Pilot Data in Poland

in Drugs Outcomes Research and Policies

Grzegorz Kardas
Michał Panek
Piotr Kuna
Janusz Cieszyński
Przemysław Kardas

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00783

8,016 views
13 citations

Review

Published on 15 Apr 2022

Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management

in Skin Allergy

Luis Felipe Ensina
Taek Ki Min
Mara Morelo Rocha Félix
Carolina Tavares de Alcântara
Célia Costa

Frontiers in Allergy

doi 10.3389/falgy.2022.840999

30,025 views
20 citations

Original Research

Published on 17 Jul 2025

Exploring the therapeutic potential of H1-antihistamines in endometriosis—A gene regulation-based perspective

in Obstetrics and Gynecology

Kameswara Bharadwaj Mantha
Mohan Kumar Gajendran

Frontiers in Medicine

doi 10.3389/fmed.2025.1538368

3,133 views

Review

Published on 12 Jan 2026

Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria

in Skin Allergy

P. Calzari
E. M. Favale
M. Cugno
R. Asero
A. V. Marzano
S. M. Ferrucci

Frontiers in Allergy

doi 10.3389/falgy.2025.1728559

1,318 views

Original Research

Published on 16 Sep 2024

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study

in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

Atsushi Fukunaga
Yasumasa Kakei
Sae Murakami
Yuji Kan
Koji Masuda
Masatoshi Jinnin
Ken Washio
Hiroo Amano
Tohru Nagano
Akihisa Yamamoto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1441478

12,234 views
2 citations

Original Research

Published on 16 Mar 2022

Altered Gut Microbiota in H1-Antihistamine-Resistant Chronic Spontaneous Urticaria Associates With Systemic Inflammation

in Microbiome in Health and Disease

Yao Song
Kena Dan
Zhengqiu Yao
Xi Yang
Bangtao Chen
Fei Hao

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.831489

8,112 views
27 citations

Original Research

Published on 29 Jan 2026

Standardized pressure provocation as an objective clinical marker of omalizumab response in delayed pressure urticaria: an open-label, real-life, prospective cohort

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

George N. Konstantinou
Indrashis Podder

Frontiers in Immunology

doi 10.3389/fimmu.2026.1768128

1,130 views

Systematic Review

Published on 24 Aug 2023

Efficacy and safety of Runzao Zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials

in Ethnopharmacology

Jian-Feng Zhang
Ying-Dong Wang
Peng Lin
Jun-Chen Li
Chen-Qi Guo
Jing-Bo Zhai
Yu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200252

4,130 views
1 citation

Articles

Primary Non-Adherence to Antihistamines—Conclusions From E-Prescription Pilot Data in Poland

Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management

Exploring the therapeutic potential of H1-antihistamines in endometriosis—A gene regulation-based perspective

Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study

Altered Gut Microbiota in H1-Antihistamine-Resistant Chronic Spontaneous Urticaria Associates With Systemic Inflammation

Standardized pressure provocation as an objective clinical marker of omalizumab response in delayed pressure urticaria: an open-label, real-life, prospective cohort

Efficacy and safety of Runzao Zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials